2bdn: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="2bdn" size="450" color="white" frame="true" align="right" spinBox="true" caption="2bdn, resolution 2.5300Å" /> '''Crystal structure...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2bdn.gif|left|200px]]<br />
[[Image:2bdn.gif|left|200px]]<br /><applet load="2bdn" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2bdn" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2bdn, resolution 2.5300&Aring;" />
caption="2bdn, resolution 2.5300&Aring;" />
'''Crystal structure of human MCP-1 bound to a blocking antibody, 11K2'''<br />
'''Crystal structure of human MCP-1 bound to a blocking antibody, 11K2'''<br />


==Overview==
==Overview==
Monocyte chemoattractant proteins (MCPs) are cytokines that direct immune, cells bearing appropriate receptors to sites of inflammation or injury and, are therefore attractive therapeutic targets for inhibitory molecules., 11K2 is a blocking mouse monoclonal antibody active against several human, and murine MCPs. A 2.5 A structure of the Fab fragment of this antibody in, complex with human MCP-1 has been solved. The Fab blocks CCR2 receptor, binding to MCP-1 through an adjacent but distinct binding site. The, orientation of the Fab indicates that a single MCP-1 dimer will bind two, 11K2 antibodies. Several key residues on the antibody and on human MCPs, were predicted to be involved in antibody selectivity. Mutational analysis, of these residues confirms their involvement in the antibody-chemokine, interaction. In addition to mutations that decreased or disrupted binding, one antibody mutation resulted in a 70-fold increase in affinity for human, MCP-2. A key residue missing in human MCP-3, a chemokine not recognized by, the antibody, was identified and engineering the preferred residue into, the chemokine conferred binding to the antibody.
Monocyte chemoattractant proteins (MCPs) are cytokines that direct immune cells bearing appropriate receptors to sites of inflammation or injury and are therefore attractive therapeutic targets for inhibitory molecules. 11K2 is a blocking mouse monoclonal antibody active against several human and murine MCPs. A 2.5 A structure of the Fab fragment of this antibody in complex with human MCP-1 has been solved. The Fab blocks CCR2 receptor binding to MCP-1 through an adjacent but distinct binding site. The orientation of the Fab indicates that a single MCP-1 dimer will bind two 11K2 antibodies. Several key residues on the antibody and on human MCPs were predicted to be involved in antibody selectivity. Mutational analysis of these residues confirms their involvement in the antibody-chemokine interaction. In addition to mutations that decreased or disrupted binding, one antibody mutation resulted in a 70-fold increase in affinity for human MCP-2. A key residue missing in human MCP-3, a chemokine not recognized by the antibody, was identified and engineering the preferred residue into the chemokine conferred binding to the antibody.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
2BDN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2BDN OCA].  
2BDN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BDN OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Bailly, V.]]
[[Category: Bailly, V.]]
[[Category: Boriack-Sjodin, P.A.]]
[[Category: Boriack-Sjodin, P A.]]
[[Category: Jarpe, M]]
[[Category: Jarpe, M]]
[[Category: Reid, C.]]
[[Category: Reid, C.]]
Line 25: Line 24:
[[Category: antibody-antigen complex]]
[[Category: antibody-antigen complex]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:01:30 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:36:42 2008''